Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Axcelis Technologies shares target raised by Craig-Hallum on growth prospects

EditorEmilio Ghigini
Published 07/12/2024, 10:12 PM
ACLS
-

On Friday, Craig-Hallum updated the price target for Axcelis Technologies (NASDAQ:ACLS) shares to $174 from the previous target of $130, reaffirming a Buy rating on the stock. The adjustment follows the company's optimistic outlook for substantial growth over the next few years.

The semiconductor equipment manufacturer anticipates its revenue to climb from a baseline of $1.1 billion in 2023 to $1.6 billion by 2027. This expected growth is attributed to several factors, including sustained development in mature markets such as silicon carbide (SiC) and silicon power, alongside anticipated recoveries in image sensor and memory spending.

Additionally, Axcelis projects some market share gains in advanced logic and foresees an increasing contribution from its spares and maintenance division, CS&I, buoyed by an expanding install base.

In terms of profitability, the company forecasts a modest increase in gross margins to over 45%, up from 43.5% in 2023. This improvement is expected to stem from a general rise in volume and a more favorable product mix, featuring higher-margin Purion products and its CS&I business.

Operating margins are also projected to grow to above 27%, compared to 23.5% in 2023, as a result of operational expense leverage, although the company plans to continue investing in ion implant research and development.

The positive adjustment in the price target comes in the wake of Axcelis's Investor Event and an encouraging pre-release of its second-quarter results. The new target of $174 is based on a 20x multiple of Craig-Hallum's 2025 earnings per share estimate of $8.70 for Axcelis Technologies.

In other recent news, Axcelis Technologies has seen significant developments in its financial and operational performance. The company reported robust Q1 2024 results, with revenues reaching $252.4 million and earnings per diluted share at $1.57.

Additionally, Axcelis has expanded its presence in Japan, opening new service offices in Chitose, Hokkaido, and Kumamoto, Kyushy to support its Purion ion implant equipment.

Analyst firms have offered mixed views on Axcelis. B.Riley increased the price target for Axcelis shares to $190, maintaining a Buy rating, after the company raised its second-quarter sales and earnings per share guidance.

Conversely, DA Davidson reduced its price target for Axcelis to $150 from $175, while still retaining a Buy rating. Craig-Hallum also upgraded Axcelis from Hold to Buy, maintaining a price target of $130.

These developments reflect Axcelis' ongoing efforts to grow and adapt in the semiconductor industry. The company's expansion into Japan and the differing outlooks from analysts highlight recent developments in Axcelis' strategic moves and financial health. As always, investors are encouraged to stay tuned for future updates from Axcelis Technologies.

InvestingPro Insights

Following the upbeat assessment by Craig-Hallum, Axcelis Technologies (NASDAQ:ACLS) showcases a strong financial standing with real-time data from InvestingPro reinforcing the company's robust market position. With a market capitalization of approximately $4.83 billion and a forward-looking P/E ratio of 19.14, Axcelis appears to be trading at a valuation that is mindful of its near-term earnings growth. The company's PEG ratio, which stands at a compelling 0.56, suggests that the stock may be undervalued given its growth prospects.

InvestingPro Tips indicate that Axcelis holds more cash than debt on its balance sheet, an indicator of financial stability that can be crucial during periods of market volatility. Additionally, the company's cash flows are reported to sufficiently cover interest payments, which is reassuring for investors concerned about debt sustainability. These factors, combined with a gross profit margin of 44.58% for the last twelve months as of Q1 2024, align well with the company's forecasted margin improvements.

For investors seeking to delve deeper into Axcelis's financial health and stock performance, InvestingPro offers a suite of additional tips, with a total of 12 more tips available for review. Interested readers can explore these insights and consider leveraging the exclusive offer of up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription using the coupon code PRONEWS24 at https://www.investing.com/pro/ACLS.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.